Brunet, Lesley Williams
Name Entries
person
Brunet, Lesley Williams
Computed Name Heading
Name Components
Name :
Brunet, Lesley Williams
Genders
Exist Dates
Biographical History
Dr. Emil “Tom” Frei, III, attended St. Louis University in St. Louis, Missouri before attending Colgate University through the Navy’s V-12 program during WW II. From there, Dr. Frei attended Yale Medical School and graduated in 1948. Dr. Frei also served during the Korean War as a physician. He began his civilian career as the Chief of Medicine at the National Cancer Institute (NCI) in 1955 before moving to MD Anderson in 1965. During his time at MD Anderson, Dr. Frei became the first Head of the Department of Development Therapeutics, which evolved into the Clinical Research Center. He continued at MD Anderson until 1972, upon which time he moved to Dana-Farber Cancer Institute in Boston, MA. During his career, Dr. Frei has authored many articles regarding the treatment of cancer, particularly the areas of Hodgkin’s disease. He has also been noted for his successful combinations of chemotherapy in children’s leukemia as well as post-surgical chemotherapy treatments. Dr. Frei has also received many awards during his career. Some of them include: Mary Lasker Foundation award (1973); Jeffrey A. Gottlieb Memorial Award (1978); NIH Distinguished Alumni Award (1990); Fellow, American Academy of Arts and Sciences (1999); Pollin Prize (2003); and AARC Lifetime Achievement Award (2004). In 2007 the Leukemia and Lymphoma Society’s Southern Nevada Chapter held the inaugural Dr. Emil Frei III Symposium, which is a continuing medical education program for oncologists, hematologists and other personnel. Dr. Frei is retired, but continues to serve as Physician-in-Chief, Emeritus, at Dana-Farber Cancer Institute.
eng
Latn
External Related CPF
Other Entity IDs (Same As)
Sources
Loading ...
Resource Relations
Loading ...
Internal CPF Relations
Loading ...
Languages Used
Subjects
Antineoplastic Combined Chemotherapy Protocols
Chemotherapy, Adjuvant
Clinical Trials as Topic
Disease
Doxorubicin
Financing, Organized
Hodgkin's disease
Hospital Departments
Hospital laboratories
Hospitals
Hospitals, Special
Houston (TX)
Interviews
Leukemia
Leukemia
Mycoplasma
Neoplasms
Oral history
Patient Isolators
Pneumonia
Randomized Controlled Trials as Topic
Remission Induction
Research